Cargando…

Prognostic Factors and Survival in Non-Small Cell Lung Cancer Patients Treated with Chemoradiotherapy

BACKGROUND: According to the literature, performance status, stage-tumor dimension and nodal status, weight loss, were the most important prognostic factors for survival in patients with locally advanced non-small cell lung cancer. AIM: To evaluate the treatment results and the prognostic variables...

Descripción completa

Detalles Bibliográficos
Autor principal:	Crvenkova, Simonida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Institute of Immunobiology and Human Genetics 2015
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877793/ https://www.ncbi.nlm.nih.gov/pubmed/27275200 http://dx.doi.org/10.3889/oamjms.2015.003

Ejemplares similares

Survival and Side Effects in Non-Small Cell Lung Cancer Patients Treated With Combination of Chemotherapy and Conformal Radiotherapy
por: Crvenkova, Simonida
Publicado: (2018)

Evaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy
por: Wen, Qiang, et al.
Publicado: (2017)

Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy
por: Liu, Jiafeng, et al.
Publicado: (2023)

Excessive splenic volume is an unfavorable prognostic factor in patients with non-small cell lung cancer treated with chemoradiotherapy
por: Guo, Jianping, et al.
Publicado: (2020)

Is Human Kallikrein 11 in Non-small Cell Lung Cancer Treated Chemoradiotherapy Associated with Survival?
por: Unal, Dilek, et al.
Publicado: (2016)

Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer
por: Wakabayashi, Yu, et al.
Publicado: (2020)

Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer
por: Katayama, H, et al.
Publicado: (2004)

Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer
por: Karetsi, Eleni, et al.
Publicado: (2012)

Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer
por: Jin, Ying, et al.
Publicado: (2013)

EP06.01-013 Differences of Oncology Treatment for Lung Cancer Patients in Pandemic COVID-19 Year: Our Clinical Experience
por: crvenkova, s., et al.
Publicado: (2022)

Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Park, Eun Young, et al.
Publicado: (2019)

Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy
por: Guan, Xiaoxiang, et al.
Publicado: (2010)

Completely Resected N0 Non-Small Cell Lung Cancer: Prognostic Factors Affecting Long-Term Survival
por: Tantraworasin, Apichat, et al.
Publicado: (2013)

Early tumor shrinkage served as a prognostic factor for patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Wei, Min, et al.
Publicado: (2018)

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
por: Satouchi, M, et al.
Publicado: (2007)

C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy
por: Frey, Alina, et al.
Publicado: (2022)

Early recurrence factors in patients with stage III non‐small cell lung cancer treated with concurrent chemoradiotherapy
por: Takahara, Yutaka, et al.
Publicado: (2022)

TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy
por: Guan, Xiaoxiang, et al.
Publicado: (2011)

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
por: Guberina, Maja, et al.
Publicado: (2021)

Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers
por: Gagnon, B, et al.
Publicado: (2013)

Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy
por: Vrankar, Martina, et al.
Publicado: (2020)

Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
por: Topkan, Erkan, et al.
Publicado: (2012)

The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
por: Koo, Tae Ryool, et al.
Publicado: (2014)

Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Bergamino, Milana, et al.
Publicado: (2019)

Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Ito, Masami, et al.
Publicado: (2012)

Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy
por: Zhang, ZiCheng, et al.
Publicado: (2014)

Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study
por: Horinouchi, Hidehito, et al.
Publicado: (2020)

Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer
por: Lee, Joohwan, et al.
Publicado: (2015)

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy
por: Kang, Min Kyu, et al.
Publicado: (2021)

Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma
por: Jeong, Hyehyun, et al.
Publicado: (2021)

Lymph node ratio is a prognostic factor for non-small cell lung cancer
por: Sun, Guangyuan, et al.
Publicado: (2015)

Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy
por: Ma, Li, et al.
Publicado: (2017)

Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
por: Khakwani, A, et al.
Publicado: (2013)

Long-term Survival of Locally Advanced Stage III Non-small Cell Lung Cancer Patients Treated with Chemoradiotherapy and Perspectives for The Treatment with Immunotherapy
por: Vrankar, Martina, et al.
Publicado: (2018)

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
por: Shen, Jinwen, et al.
Publicado: (2017)

Non-small cell lung cancer in never smokers: a clinical entity to be identified
por: Santoro, Ilka Lopes, et al.
Publicado: (2011)

Procalcitonin Level in Non-Small Cell Lung Cancer Patients among Indonesian Population
por: Soeroso, Noni Novisari, et al.
Publicado: (2018)

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
por: Sher, David J.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_su9d9uvanpnjo9isp91205lq31